Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.

@article{Wagner2011FluorodeoxyglucosePE,
  title={Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.},
  author={Thomas W Wagner and N Meyer and Slimane Zerdoud and Anne Julian and Christine Chevreau and Pierre Payoux and Frederic Courbon},
  journal={The British journal of dermatology},
  year={2011},
  volume={164 6},
  pages={1235-40}
}
BACKGROUND Positron emission tomography (PET) using fluorodeoxyglucose (FDG) has proven to be more sensitive and accurate than other imaging modalities for the detection of distant metastases in patients with melanoma. Sentinel lymph node (SLN) status is the most important prognostic factor in melanoma patients with no evidence of distant metastasis. OBJECTIVES To assess the rate of distant metastases in patients with a positive SLN biopsy (SLNB). METHODS Forty-six consecutive patients with… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Melanoma and pregnancy.

The Australasian journal of dermatology • 2017

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Final version of 2009 AJCC melanoma staging and classification.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2009

Sentinel lymph node biopsy for melanoma : indications and rationale

DL Morton, JF Thompson, AJ Cochran
Cancer Control • 2009

Similar Papers

Loading similar papers…